Tech Company Financing Transactions
IntrepidaBio Funding Round
IntrepidaBio, based in San Diego, secured $9.5 million from Canaan Partners, Indaco Venture Partners and Sofinnova Ventures.
Transaction Overview
Company Name
Announced On
10/23/2019
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds for the investigational new drug (IND) application-enabling studies of its lead oncology program.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9920 Pacific Heights Blvd. 149
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
IntrepidaBio is a preclinical biotechnology company dedicated to developing cures for cancer through drugs that alter the body's first line of defense, innate immunity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joel Martin
Chief Scientific Officer
Olivier Laurent
Browse more venture capital transactions:
Prev: 10/23/2019: 410 Medical venture capital transaction
Next: 10/23/2019: Zoox venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. All VC database entries reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs